Katherine Neville

July 02, 2013 | Inside Counsel

In a 5-3 decision in FTC v. Actavis, the Supreme Court addressed the question of whether reverse settlement, or pay for delay, payments from an innovator drug company to a generic drugmaker to delay entry into the market constitute an antitrust violation.

By Katherine Neville

16 minute read

June 04, 2013 | Inside Counsel

The Supreme Court recently granted a petition for certiorari to Medtronic, appealing the Federal Circuits ruling in Medtronic v. Boston Scientific.

By Katherine Neville

7 minute read

May 07, 2013 | Inside Counsel

On April 15, the Supreme Court heard oral argument in the highly anticipated <em> Association for Molecular Pathology v. Myriad Genetics</em> case.

By Katherine Neville

14 minute read

April 23, 2013 | Inside Counsel

The Supreme Court has taken an increased interest in patent cases in recent years. Two cases important to entities that file business method patents, software patents and medical diagnostics are Bilski v. Kappos and Mayo Collaborative Services v. Prometheus Laboratories, Inc.

By Katherine Neville

21 minute read

March 26, 2013 | Inside Counsel

In the Federal Circuits recent 2-1 decision In re Hubbell, the court clarified the scope of the doctrine of obviousness-type double patenting as it applies to applications and patents that have overlapping inventors, but are not commonly owned.

By Katherine Neville

17 minute read

February 26, 2013 | Inside Counsel

It has always been important to keep thorough records of conception and reduction to practice of an invention in case of an interference between two patents or to antedate a prior art reference, usually accomplished by signing and witnessing laboratory notebooks.

By Katherine Neville

6 minute read